Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3-Reference-Cited by-同舟云学术

Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3

Published:2012-09 Issue:11 Volume:13 Page:1034-1041
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Fu Siqing,li Yanfang,Huang Jie,Liu Tao,Hong Zhen,Chen Aiping,Bast Robert C.,Kavanagh John J.,Gershenson David M.,Sood Anil K.,Hu Wei

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.21045

Reference36 articles.

1. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

2. Kavanagh JJSS, Pecoreli S, Dipertrillo A, Einhorn N. Chemotherapy in advanced ovarian cancer. Cambrige, MA: Blackwell Scientific Publications, 1998.

3. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

4. Verschraegen CFDK, Johnes LA. Biology of gynecologic cancers. Cambrige, MA: Blackwell Scientific Publications, 1998.

5. Long-term results and pharmacokinetics of high-dose paclitaxel in patients with refractory epithelial ovarian carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation;Life;2022-06-10

2. Aurora kinase: An emerging potential target in therapeutics;Protein Kinase Inhibitors;2022

3. Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms;Diagnostic Pathology;2021-10-27

4. AURKB promotes tumorigenesis and carboplatin resistance by regulating the ERK pathway in neuroblastoma cells;International Journal of Neuroscience;2021-08-16

5. Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma;Experimental Biology and Medicine;2021-04-25